SPECTRA PRODS INC (SSA.CA) Fundamental Analysis & Valuation

TSX-V:SSA • CA84757D2095

Current stock price

0.175 CAD
+0 (+2.94%)
Last:

This SSA.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. SSA.CA Profitability Analysis

1.1 Basic Checks

  • SSA had positive earnings in the past year.
  • SSA had a positive operating cash flow in the past year.
  • In the past 5 years SSA has always been profitable.
  • Each year in the past 5 years SSA had a positive operating cash flow.
SSA.CA Yearly Net Income VS EBIT VS OCF VS FCFSSA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.46%, SSA is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 5.25%, SSA is doing worse than 80.00% of the companies in the same industry.
  • SSA has a Return On Invested Capital of 4.80%. This is amonst the worse of the industry: SSA underperforms 80.00% of its industry peers.
  • SSA had an Average Return On Invested Capital over the past 3 years of 8.50%. This is above the industry average of 6.35%.
Industry RankSector Rank
ROA 4.46%
ROE 5.25%
ROIC 4.8%
ROA(3y)8.04%
ROA(5y)11.02%
ROE(3y)9.81%
ROE(5y)13.13%
ROIC(3y)8.5%
ROIC(5y)12.06%
SSA.CA Yearly ROA, ROE, ROICSSA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

  • SSA has a better Profit Margin (5.73%) than 100.00% of its industry peers.
  • SSA's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 7.49%, SSA is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • SSA's Operating Margin has declined in the last couple of years.
  • With an excellent Gross Margin value of 46.27%, SSA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SSA has declined.
Industry RankSector Rank
OM 7.49%
PM (TTM) 5.73%
GM 46.27%
OM growth 3Y-25.85%
OM growth 5Y-13.88%
PM growth 3Y-15.05%
PM growth 5Y-23.9%
GM growth 3Y-5.9%
GM growth 5Y-3.54%
SSA.CA Yearly Profit, Operating, Gross MarginsSSA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

10

2. SSA.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SSA is still creating some value.
  • Compared to 1 year ago, SSA has less shares outstanding
  • Compared to 5 years ago, SSA has less shares outstanding
  • Compared to 1 year ago, SSA has an improved debt to assets ratio.
SSA.CA Yearly Shares OutstandingSSA.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
SSA.CA Yearly Total Debt VS Total AssetsSSA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

2.2 Solvency

  • An Altman-Z score of 3.69 indicates that SSA is not in any danger for bankruptcy at the moment.
  • SSA has a Altman-Z score of 3.69. This is amongst the best in the industry. SSA outperforms 100.00% of its industry peers.
  • The Debt to FCF ratio of SSA is 0.89, which is an excellent value as it means it would take SSA, only 0.89 years of fcf income to pay off all of its debts.
  • SSA has a Debt to FCF ratio of 0.89. This is amongst the best in the industry. SSA outperforms 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.05 indicates that SSA is not too dependend on debt financing.
  • The Debt to Equity ratio of SSA (0.05) is better than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.89
Altman-Z 3.69
ROIC/WACC0.58
WACC8.26%
SSA.CA Yearly LT Debt VS Equity VS FCFSSA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K -500K 1M 1.5M

2.3 Liquidity

  • A Current Ratio of 8.67 indicates that SSA has no problem at all paying its short term obligations.
  • SSA's Current ratio of 8.67 is amongst the best of the industry. SSA outperforms 100.00% of its industry peers.
  • A Quick Ratio of 7.57 indicates that SSA has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 7.57, SSA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.67
Quick Ratio 7.57
SSA.CA Yearly Current Assets VS Current LiabilitesSSA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

1

3. SSA.CA Growth Analysis

3.1 Past

  • SSA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.17%.
  • The earnings per share for SSA have been decreasing by -27.10% on average. This is quite bad
  • The Revenue has grown by 8.53% in the past year. This is quite good.
  • The Revenue has been decreasing by -4.04% on average over the past years.
EPS 1Y (TTM)-4.17%
EPS 3Y-13.54%
EPS 5Y-27.1%
EPS Q2Q%0%
Revenue 1Y (TTM)8.53%
Revenue growth 3Y-0.72%
Revenue growth 5Y-4.04%
Sales Q2Q%22.7%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SSA.CA Yearly Revenue VS EstimatesSSA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

1

4. SSA.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • SSA is valuated rather expensively with a Price/Earnings ratio of 17.50.
  • SSA's Price/Earnings ratio is rather expensive when compared to the industry. SSA is more expensive than 80.00% of the companies in the same industry.
  • SSA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.23.
Industry RankSector Rank
PE 17.5
Fwd PE N/A
SSA.CA Price Earnings VS Forward Price EarningsSSA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SSA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • SSA's Price/Free Cash Flow ratio is rather expensive when compared to the industry. SSA is more expensive than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.2
EV/EBITDA 1.18
SSA.CA Per share dataSSA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. SSA.CA Dividend Analysis

5.1 Amount

  • No dividends for SSA!.
Industry RankSector Rank
Dividend Yield 0%

SSA.CA Fundamentals: All Metrics, Ratios and Statistics

SPECTRA PRODS INC

TSX-V:SSA (3/20/2026, 7:00:00 PM)

0.175

+0 (+2.94%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners27.43%
Inst Owner ChangeN/A
Ins Owners8.51%
Ins Owner ChangeN/A
Market Cap2.31M
Revenue(TTM)1.74M
Net Income(TTM)99.60K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.5
Fwd PE N/A
P/S 1.33
P/FCF 12.2
P/OCF 12.2
P/B 1.22
P/tB 1.22
EV/EBITDA 1.18
EPS(TTM)0.01
EY5.71%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY8.2%
OCF(TTM)0.01
OCFY8.2%
SpS0.13
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.18
Profitability
Industry RankSector Rank
ROA 4.46%
ROE 5.25%
ROCE 6.53%
ROIC 4.8%
ROICexc 18.9%
ROICexgc 18.9%
OM 7.49%
PM (TTM) 5.73%
GM 46.27%
FCFM 10.91%
ROA(3y)8.04%
ROA(5y)11.02%
ROE(3y)9.81%
ROE(5y)13.13%
ROIC(3y)8.5%
ROIC(5y)12.06%
ROICexc(3y)25.04%
ROICexc(5y)32.76%
ROICexgc(3y)25.04%
ROICexgc(5y)32.76%
ROCE(3y)11.57%
ROCE(5y)16.41%
ROICexgc growth 3Y-19.46%
ROICexgc growth 5Y-7.33%
ROICexc growth 3Y-19.46%
ROICexc growth 5Y-7.33%
OM growth 3Y-25.85%
OM growth 5Y-13.88%
PM growth 3Y-15.05%
PM growth 5Y-23.9%
GM growth 3Y-5.9%
GM growth 5Y-3.54%
F-Score6
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.89
Debt/EBITDA 0.52
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 21
Cash Conversion 100.21%
Profit Quality 190.46%
Current Ratio 8.67
Quick Ratio 7.57
Altman-Z 3.69
F-Score6
WACC8.26%
ROIC/WACC0.58
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)225.95%
Profit Quality(5y)198%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.17%
EPS 3Y-13.54%
EPS 5Y-27.1%
EPS Q2Q%0%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.53%
Revenue growth 3Y-0.72%
Revenue growth 5Y-4.04%
Sales Q2Q%22.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.45%
EBIT growth 3Y-26.38%
EBIT growth 5Y-17.36%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.62%
FCF growth 3Y-7.27%
FCF growth 5Y-9.48%
OCF growth 1Y-37.62%
OCF growth 3Y-7.27%
OCF growth 5Y-9.92%

SPECTRA PRODS INC / SSA.CA Fundamental Analysis FAQ

What is the fundamental rating for SSA stock?

ChartMill assigns a fundamental rating of 5 / 10 to SSA.CA.


Can you provide the valuation status for SPECTRA PRODS INC?

ChartMill assigns a valuation rating of 1 / 10 to SPECTRA PRODS INC (SSA.CA). This can be considered as Overvalued.


What is the profitability of SSA stock?

SPECTRA PRODS INC (SSA.CA) has a profitability rating of 5 / 10.


What are the PE and PB ratios of SPECTRA PRODS INC (SSA.CA) stock?

The Price/Earnings (PE) ratio for SPECTRA PRODS INC (SSA.CA) is 17.5 and the Price/Book (PB) ratio is 1.22.


Can you provide the financial health for SSA stock?

The financial health rating of SPECTRA PRODS INC (SSA.CA) is 10 / 10.